Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Determination of Pneumothorax Post Lung Biopsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02840032
Recruitment Status : Withdrawn (No subjects enrolled)
First Posted : July 21, 2016
Last Update Posted : May 3, 2018
Sponsor:
Information provided by (Responsible Party):
University of Minnesota

Brief Summary:
Bedside ultrasonography for detection of pneumothorax after transbronchial lung biopsies in lung transplant patients

Condition or disease
Pneumothorax

Detailed Description:
The patients who undergo transbronchial forceps lung biopsies get a routine CXR after the biopsies are performed. The reason for CXR is to find out if pneumothorax occurred or not. CXR is required patient transportation and interpretation by the radiologist as well as time consuming. Instead, we are planning to perform bedside ultrasound to determine if pneumothorax occurred or not

Layout table for study information
Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Role of Ultrasonography in the Diagnosis of Pneumothorax Following Transbronchial Biopsy in LungTransplant Patients.
Study Start Date : July 2016
Estimated Primary Completion Date : August 2017
Estimated Study Completion Date : August 2017

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Determination of pneumothorax after transbronchial lung biopsy [ Time Frame: 2 hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Lung transplant patients who undergo routine bronchoscopic biopsy procedure for rejection determination
Criteria

Inclusion Criteria:

  • Any lung transplant patient who undergoes to bronchoscopic lung biopsy

Exclusion Criteria:

  • Patients develop respiratory failure during the procedure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02840032


Locations
Layout table for location information
United States, Minnesota
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Sponsors and Collaborators
University of Minnesota
Investigators
Layout table for investigator information
Principal Investigator: Erhan Dincer University of Minnesota
Layout table for additonal information
Responsible Party: University of Minnesota
ClinicalTrials.gov Identifier: NCT02840032    
Other Study ID Numbers: 1606M88672
First Posted: July 21, 2016    Key Record Dates
Last Update Posted: May 3, 2018
Last Verified: April 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumothorax
Pleural Diseases
Respiratory Tract Diseases